GLHRL.BO · BSE

Global Longlife Hospital and R

₹14.84

+4.29% (+₹0.61)

Prev. close

₹14.23

Volume

1,56,000

As of

18 Sept 2026

Price history

₹14.84+₹4.34 (+41.33%) · 3M
16 Jun 202618 Sept 2026
₹14.97₹9.4716 Jun10 Jul04 Aug26 Aug18 Sept
Daily closes · updates after each session

No analyst calls on this stock in the last 90 days yet.

Explore by date range →

Analyst opinions

No analyst calls on Global Longlife Hospital and R in the last 90 days.

Fundamentals

About Global Longlife Hospital and R

Global Longlife Hospital and Research Limited, a multi-speciality tertiary care hospital, provides medical and surgical specialities services in India. It offers medical services, such as oncology, ophthalmology, allergy and immunology, pain management, pulmonology, anaesthesiology, cardiology, dermatology, critical care, diabetes and endocrinology, GI medicine, gynecology, infectious disease, nephrology, and neurology; and surgical services, including CVTS, joint replacement orthopaedics, spine surgery, general surgery, onco surgery, GI surgery, neurosurgery, ENT, plastic surgery, trauma centre, urology, laparoscopic surgery, gynaecology, dental surgery, and vascular surgery. It also provides radiology services comprising mammography, CT scan, X-ray, ultrasound, endoscopy, and sonography; pathology services, such as microbiology, biochemistry, clinical pathology, cyto pathology, haematology, and serology; and other services that include dialysis, pharmacy, ambulance, dietary, and physiotherapy services. Global Longlife Hospital and Research Limited was incorporated in 2012 and is based in Ahmedabad, India.

Details

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Mr. Dhruv Sureshkumar Jani

Headquarters

Ahmedabad

Employees

3

Key stats

Market cap

₹15.58 Cr

EPS (TTM)

₹-1.64

Beta (1Y · daily vs NIFTY 50)

-0.40

Beta (5Y · monthly vs NIFTY 50)

0.17

Shares float

77.16 L

Financial Performance

01 · Financials

-20 Cr0 Cr20 Cr40 Cr-100%-75%-50%-25%0%FY23FY24FY25FY26
RevenueNet incomeEBITDARevenue growth YoY

The first plotted growth figure is computed against Mar 2022 revenue as filed with BSE; the two sources' revenue definitions differ by 0.0% on Mar 2023. FY23 growth needs FY22 filings, which the data source doesn't provide.

02 · Earnings Per Share (EPS)

-3035FY22FY23FY24FY25

04 · Operating Efficiency (Growth Rates)

Balance-sheet-based · pre-FY23 not filed in verifiable form

-100%-75%-50%-25%0%FY23FY24FY25FY26
SalesFixed assetsTrade receivablesInventory

05 · Capital Structure & Asset Utilization

Pre-FY23 not filed in verifiable form

0 Cr20 Cr40 Cr60 Cr80 Cr0.2×0.4×0.6×FY23FY24FY25FY26
Total assetsTotal debtDebt / equityAsset turnover

Asset turnover needs a prior year of assets — omitted for the earliest available year.

06 · Asset Base Composition

Pre-FY23 not filed in verifiable form

0 Cr20 Cr40 Cr60 Cr80 CrFY22FY23FY24FY25FY26
Fixed assetsCurrent assetsOther assets

07 · Debt Level & Coverage

Pre-FY23 not filed in verifiable form

-50 Cr-25 Cr0 Cr25 CrFY22FY23FY24FY25FY26
DebtFree cash flowCash & equivalents

08 · Profit & Loss

Annual

Line itemFY22FY23FY24FY25FY26
₹32.82 Cr₹23.50 Cr₹13.51 Cr₹57.73 L₹0
EBITDA₹8.25 Cr₹4.19 Cr₹-31.18 L₹85.73 L₹-98.77 L
₹3.57 Cr₹1.83 Cr₹-2.19 Cr₹19.87 L₹-1.72 Cr
Diluted EPS₹3.4₹1.79₹-2.08₹0.19

Depreciation & amortisation, Pretax income, Tax provision, Interest expense, Diluted EPS have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

09 · Balance Sheet

Annual

Line itemFY22FY23FY24FY25FY26
₹75.94 Cr₹41.73 Cr₹26.84 Cr₹23.76 Cr
₹9.30 Cr₹12.74 Cr₹0₹0
Stockholders' equity₹64.29 Cr₹25.93 Cr₹26.79 Cr₹23.75 Cr

Total assets, Current assets, Trade receivables, Cash & equivalents, Non-current assets, Fixed assets, Total debt, Long-term debt, Current (short-term) debt, Others, Stockholders' equity have filed figures for only some of the years shown — the missing years are left blank rather than estimated. Inventory shows ₹0 for 2025-03-31, 2026-03-31 — this deck's own annual-report reading has no Inventory figure for this filer in any year shown (2025-03-31, 2026-03-31, 2022-03-31 alike); the ₹0 shown here comes from this filer's own reported data feed rather than this deck's own extraction, and is positively consistent with a filer that holds no physical inventory (typical for lenders and other financial-services companies) rather than a display default. 2022-03-31 has no Inventory figure reaching this deck at all — not shown as zero, not shown as positive — left blank rather than assumed to match the other years.

Annual only — the data source doesn’t publish quarterly balance-sheet detail for most NSE-listed companies.

10 · Cash Flow Statement

Annual

Line itemFY22FY23FY24FY25FY26
₹-40.42 Cr₹-5.07 Cr₹12.32 Cr₹-4.51 Cr
Investing cash flow₹-1.90 Cr₹-81.75 L₹21.80 Cr₹3.52 L
₹45.70 Cr₹2.67 Cr₹-13.01 Cr₹-3,000
Capital expenditure₹-47.54 L₹-2.00 Cr₹-1.05 Cr₹-7.24 L
End cash position₹3.60 Cr₹38.54 L₹21.49 Cr₹17.02 Cr

Operating cash flow, Depreciation & amortization, Change in working capital, Investing cash flow, Financing cash flow, Debt issued, Debt repaid, Capital expenditure, End cash position have filed figures for only some of the years shown — the missing years are left blank rather than estimated.

Annual only — the data source has no quarterly cash-flow-statement coverage.

12 · Peer Comparison

Healthcare

Company
Sun Pharmaceutical Industries Limited₹4.48 L Cr₹1,837.337.05.3613.7%0.06+11.9%+11.4%
Divi's Laboratories Limited₹2.47 L Cr₹9,37583.314.7715.3%0.00+12.3%+53.4%
Torrent Pharmaceuticals Limited₹1.83 L Cr₹4,87576.921.8225.8%1.79+21.5%+37.4%
Apollo Hospitals Enterprise Limited₹1.26 L Cr₹8,944.560.413.3020.5%0.90+15.7%+13.9%
Lenskart Solutions Limited₹1.18 L Cr₹707.2179.913.485.6%0.35+35.4%
Zydus Lifesciences Limited₹1.13 L Cr₹1,16025.34.1818.6%0.46+18.4%+10.7%
Cipla Limited₹1.10 L Cr₹1,376.332.53.1911.3%0.02+2.1%-11.8%
Laurus Labs Limited₹1.05 L Cr₹1,95496.419.8616.8%0.48+22.0%+111.6%
Max Healthcare Institute Limited₹1.01 L Cr₹1,049.369.89.3913.4%0.32+19.0%-10.6%
Dr. Reddy's Laboratories Limited₹97,876.16 Cr₹1,18529.62.6011.4%0.21+3.2%-10.4%
Manipal Health Enterprises Limited₹97,364.22 Cr₹738.95146.611.567.8%1.53+18.0%
Global Longlife Hospital and R₹15.72 Cr₹14.970.66-7.2%0.00-100.0%-41.3%

Ranked by market cap within Healthcare, same metrics as the Fundamentals screener. Click a column to sort.

Documents

Official documents linked from their sources — offer documents as filed with SEBI (sebi.gov.in), annual reports and earnings-call transcripts as published on BSE (bseindia.com) and NSE (nseindia.com). Links open the source's own hosting; nothing is re-hosted here.

No stock news captured yet.